DETECTION AND DEVELOPMENT OF NON AVAILABLE MEDICINES (NAM) IN ARGENTINA

L.Y. HERGERT; KOMROVSKY, F; FONTANA, D; R. PAGLIERO; MURATURE, D; SOBRERO, C; AHUMADA, A; TOMIO, MJ; M. R. MAZZIERI

Córdoba, Argentina

Encuentro; 1st Annual RICiFA Meeting (International Meeting on Pharmaceutical Sciences); 2010

Facultad de Ciencias Químicas, Universidad Nacional de Córdoba-Facultad de Ciencias Bioquímicas y Farmacéuticas, Universidad Nacional de Rosario

Pharmacoepidemiological studies were useful for identifying NAM and related situations. Hemina- UNC and PASS-EXT were developed under GMP standards at lab-scale production. At present, there is a batch to be used as pharmaceutical compounding. We are carrying out actions to transfer the results to national production laboratories to market Hemin and PASS in Argentina.